it's always been boom or bust, and starting to look much more like bust. Too bad, as they had one of the few potential drugs post Xtandi. Likely drug just isn't sufficiently potent.
As to whether the drug is doing anything, it would be nice to see individual PSA graphs. if prior to the drug the PSA levels were shooting up, then even a moderate decline might mean something.
Market Data 
Markets 
AI
